Education
About Us
Working with TipRanks
Follow Us
Eurobio-Scientific SA (DE:E8TN)
FRANKFURT:E8TN
E8TN Stock Chart & Stats
€24.15
€0.00(0.00%)
At close: 4:00 PM EST
€24.15
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€23.05 - €26.30
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€243.63M
Enterprise Value€244.21M
Total Cash (Recent Filing)€23.07M
Total Debt (Recent Filing)€34.05M
Price to Earnings (P/E)102.9
Beta-0.51
Next Earnings
Apr 15, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.23
Shares Outstanding10,248,871
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-6.95
Price to Book (P/B)1.45
Price to Sales (P/S)1.67
P/FCF Ratio19.24
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
E8TN FAQ
What was Eurobio-Scientific SA’s price range in the past 12 months?
Eurobio-Scientific SA lowest stock price was €23.05 and its highest was €26.30 in the past 12 months.
What is Eurobio-Scientific SA’s market cap?
Eurobio-Scientific SA’s market cap is €243.63M.
When is Eurobio-Scientific SA’s upcoming earnings report date?
Eurobio-Scientific SA’s upcoming earnings report date is Apr 15, 2026 which is in 113 days.
How were Eurobio-Scientific SA’s earnings last quarter?
Eurobio-Scientific SA released its earnings results on Sep 24, 2025. The company reported €0.235 earnings per share for the quarter, beating the consensus estimate of N/A by €0.235.
Is Eurobio-Scientific SA overvalued?
According to Wall Street analysts Eurobio-Scientific SA’s price is currently Overvalued.
Does Eurobio-Scientific SA pay dividends?
Eurobio-Scientific SA does not currently pay dividends.
What is Eurobio-Scientific SA’s EPS estimate?
Eurobio-Scientific SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Eurobio-Scientific SA have?
Eurobio-Scientific SA has 10,248,871 shares outstanding.
What happened to Eurobio-Scientific SA’s price movement after its last earnings report?
Eurobio-Scientific SA reported an EPS of €0.235 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.395%.
Which hedge fund is a major shareholder of Eurobio-Scientific SA?
Currently, no hedge funds are holding shares in DE:E8TN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Eurobio-Scientific SA
Eurobio Scientific Société anonyme designs, develops, and commercializes specialty diagnostic products in the areas of transplantation, infectious diseases, life-science, and cancer. The company offers Tetanus Quick Stick, a test that is used in emergency clinics for the determination of the tetanus vaccination status of a patient; and commercializes cell culture media, molecular biology reagents, and proprietary antibodies. Its in-house development products include the BJI InoPlex, a multiplex serological test used for the diagnosis of prosthetic joint infections; EBX-044 PCR test to enable the identification of SARS-CoV-2 variants; and licensed products comprise AlloMap, a gene-expression profiling based blood test for the surveillance of heart-transplant patients. The company was formerly known as Diaxonhit and changed its name to Eurobio Scientific Société anonyme in June 2018. Eurobio Scientific Société anonyme was incorporated in 1997 and is headquartered in Les Ulis, France.
Technical Analysis
Novacyt
―
Diagnostic Medical Systems
―
Ikonisys SA
―
Median Technologies
―
Euroapi SA
―